Enbrel 50 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FJB6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,078
Award facts
- Contract value 100% obligated
- $13,078.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,078.04 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL syringes. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp holds a significant role in supporting federal medical procurement needs for the Department of Defense and related healthcare systems. The company's contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products and medical supplies through competitively awarded delivery orders with the DLA. This particular delivery order for Enbrel, a specialty medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, reflects the company's continued capability to fulfill federal medical supply requirements for military personnel and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJB6X?
SPE2DR26FJB6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FJB6X worth?
The government has obligated $13,078 on SPE2DR26FJB6X.
Is contract SPE2DR26FJB6X an order under another contract?
Yes. SPE2DR26FJB6X is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB6X competed?
The extent of competition for SPE2DR26FJB6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award